22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Update

22nd Century Group, Inc. (NASDAQ:XXII) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 91,500 shares, an increase of 1,933.3% from the December 31st total of 4,500 shares. Approximately 19.5% of the shares of the company are short sold. Based on an average daily volume of 109,400 shares, the short-interest ratio is presently 0.8 days.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of 22nd Century Group in a report on Saturday, January 18th. StockNews.com cut shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Tuesday, December 31st.

22nd Century Group Price Performance

NASDAQ XXII traded down $0.49 during trading hours on Tuesday, reaching $4.45. The company’s stock had a trading volume of 157,158 shares, compared to its average volume of 3,052,195. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93. 22nd Century Group has a 1-year low of $3.90 and a 1-year high of $581.85. The company’s 50-day moving average is $8.09 and its two-hundred day moving average is $34.92. The firm has a market capitalization of $2.45 million, a price-to-earnings ratio of 0.00 and a beta of 1.59.

22nd Century Group (NASDAQ:XXII) last issued its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share for the quarter. The company had revenue of $5.95 million for the quarter.

Hedge Funds Weigh In On 22nd Century Group

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP acquired a new stake in 22nd Century Group, Inc. (NASDAQ:XXII) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group at the end of the most recent quarter. 18.06% of the stock is owned by institutional investors.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.